NHS (Neuberger Berman High Yield Strategies Fund) Total Receivables: $11.81 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NHS Neuberger Berman High Yield Strategies Fund Inc NHS
44 GF Score
Price $6.20
GF Value $7.23
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Neuberger Berman High Yield Strategies Fund Total Receivables?

Neuberger Berman High Yield Strategies Fund NHS -0.48% 44 Total Receivables is $11.81 Mil as of Apr. 2026. GuruFocus rates NHS with a GF Score™ of 44/100 and a GF Value™ of $7.23 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Neuberger Berman High Yield Strategies Fund's Total Receivables for the quarter that ended in Apr. 2026 was $11.81 Mil.

Neuberger Berman High Yield Strategies Fund Total Receivables Related Terms

Neuberger Berman High Yield Strategies Fund Total Receivables Historical Data

* Premium members only.

The historical data trend for Neuberger Berman High Yield Strategies Fund's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neuberger Berman High Yield Strategies Fund Total Receivables Chart

Neuberger Berman High Yield Strategies Fund Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.14 6.17 7.91 5.77 5.59

Neuberger Berman High Yield Strategies Fund Semi-Annual Data
Oct16 Apr17 Oct17 Apr18 Oct18 Apr19 Oct19 Apr20 Oct20 Apr21 Oct21 Apr22 Oct22 Apr23 Oct23 Apr24 Oct24 Apr25 Oct25 Apr26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.39 5.77 7.37 5.59 11.81
NHS
44GF Score
Neuberger Berman High Yield Strategies Fund Inc NHS
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neuberger Berman High Yield Strategies Fund Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of $11.81 Mil mean?
Neuberger Berman High Yield Strategies Fund (NHS) has a Total Receivables of $11.81 Mil as of Apr. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Neuberger Berman High Yield Strategies Fund and its competitors.
Is Neuberger Berman High Yield Strategies Fund's Total Receivables too high?
Neuberger Berman High Yield Strategies Fund's current Total Receivables is $11.81 Mil. Overall, Neuberger Berman High Yield Strategies Fund has a GF Score™ of 44/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Neuberger Berman High Yield Strategies Fund's Total Receivables compare to NRO and TPVG?
Neuberger Berman High Yield Strategies Fund's Total Receivables of $11.81 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for an Asset Management company?
A good Total Receivables depends on the Asset Management industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Neuberger Berman High Yield Strategies Fund and its competitors. Neuberger Berman High Yield Strategies Fund's current Total Receivables is $11.81 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuberger Berman High Yield Strategies Fund stock overvalued right now?
Based on GuruFocus' analysis, Neuberger Berman High Yield Strategies Fund (NHS) is currently considered Modestly Undervalued. The stock's GF Value™ is $7.23, compared to a current price of $6.20 — trading 14.2% below its estimated fair value. The current Total Receivables is $11.81 Mil. Neuberger Berman High Yield Strategies Fund's overall GF Score™ is 44/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Neuberger Berman High Yield Strategies Fund (NHS), the current Total Receivables is $11.81 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Neuberger Berman High Yield Strategies Fund (NHS) Overvalued in 2026?

Based on GuruFocus' analysis, Neuberger Berman High Yield Strategies Fund stock appears to be undervalued. The current stock price of $6.20 is trading 14.2% below its estimated GF Value™ of $7.23. GuruFocus considers Neuberger Berman High Yield Strategies Fund to be Modestly Undervalued.

Key valuation signals for NHS:

  • Total Receivables: $11.81 Mil
  • GF Value™: $7.23 vs. price of $6.20 (14.2% below fair value)
  • GF Score™: 44/100 with 6 warning signs

No single metric tells the full story. See the NHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Neuberger Berman High Yield Strategies Fund Business Description

Address c/o Neuberger Berman Investment Advisers LLC, 1290 Avenue of the Americas, New York, NY, USA, 10104-0002
Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.
44GF Score

Get the complete analysis for NHS

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.20
Price
$7.23
GF Value